The microsurgical composite tissues allotransplantation (CTA) is an emerging avenue in reconstructive surgery. Improvements in the immunosuppressive therapy and in the immunological induction of tolerance between host and donor allow for customized limb reconstruction, with limited graft alteration, and decreased exposure to immunosuppressive drugs. Several clinical cases with a potential use of CTA are described.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.anplas.2007.04.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!